Cor Vasa 2020, 62(4):399-404 | DOI: 10.33678/cor.2020.031

(Athlete with pacemaker or cardioverter-defibrillator)

Otakar Jiravskýa,b,c, Bogna Jiravská Godulaa,c,d, Jan Chovančíka, Radim ©pačeka, Libor ©kňouřila, Martin Fialab,e
a Kardiocentrum, Nemocnice Podlesí, a.s., Třinec
b Lékařská fakulta Masarykovy univerzity, Brno
c Sportovní ambulance, s.r.o.
d Poliklinika Agel, Dopravní zdravotnictví a.s.
e Neuron Medical - Centrum kardiovaskulární péče, Brno

The Czech Republic is one of the leaders in the number of implantations of pacemakers and defibrillators in Europe. Increasingly, people in the younger generation may have one of the implants. Cardiologists are then confronted with questions and asked for recommendations about conditions a patient with an implanted pacemaker or defibrillator can engage in the sports activity. This care requires specific cardiological educa- tion along with an understanding of the athlete's mind and desires. The emerging sub-specialization of sports cardiology answers the above-mentioned requirements and becomes a bridge between the world of sports and the world of patients with cardiovascular disease. In this review, the currently published data on individual aspects of the sport with an implanted pacemaker and defibrillator are summarized in an abbreviated form. Issues of indication of implants, return to sports activities after implantation, care of the generator area, issues of electrode durability in athletes, specifica- tions of system programming in athletes, stress testing are discussed. Finally, the facts about the eligibility of an athlete with an implanted system for sport are summarized.

Keywords: Eligibility for sport, Implantable cardioverter- -defibrillator, Permanent pacemaker, Sudden cardiac death of an athlete

Received: April 16, 2020; Revised: April 24, 2020; Accepted: April 24, 2020; Published: September 16, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jiravský O, Jiravská Godula B, Chovančík J, ©paček R, ©kňouřil L, Fiala M. (Athlete with pacemaker or cardioverter-defibrillator). Cor Vasa. 2020;62(4):399-404. doi: 10.33678/cor.2020.031.
Download citation

References

  1. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. The Task Force on cardiac pacing and resynchronization therapy of the European Societyof Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-2329. Go to original source...
  2. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;17:1601-1687. Go to original source...
  3. Asif IM, Price D, Fisher LA, et al. Stages of psychological impact after diagnosis with serious or potentially lethal cardiac disease in young competitive athletes: A new model. J Electrocardiol 2015;48:298-310. Go to original source... Go to PubMed...
  4. Lampert R, Saul JP. Athlete with a Device: Implantable Cardioverter Defibrillators and Pacemakers. In: Lawless CE, ed. Sports Cardiology Essentials. New York, NY: Springer New York, 2011:333-344. Go to original source...
  5. D'Souza A, Bucchi A, Johnsen AB, et al. Exercise training reduces resting heart rate via downregulation of the funny channel HCN4. Nat Commun 2014;5:1-12. Go to original source... Go to PubMed...
  6. Heidbüchel H. Implantable Cardioverter Defibrillator Therapy in Athletes. Cardiol Clin 2007;25:467-482. Go to original source... Go to PubMed...
  7. Catto V, Dessanai MA, Sommariva E, et al. S-ICD is effective in preventing sudden death in arrhythmogenic cardiomyopathy athletes during exercise. Pacing Clin Electrophysiol 2019;42:1269-1272. Go to original source... Go to PubMed...
  8. Şimşek EÇ, Güvendi EU, Şimşek A, et al. The effect on upper extremity functions of cardiac electronic device placement on the dominant hand side. J Arrhythmia 2019;35:279-286. Go to original source... Go to PubMed...
  9. Marine JE, Brinker JA. Techniques of Pacemaker Implantation and Removal. In: Cardiac Pacing and ICDs. John Wiley & Sons, Ltd, 2014:150-210. Go to original source...
  10. Johnson JN, Ackerman MJ. Return to play? Athletes with congenital long QT syndrome. Br J Sports Med 2013;47:28-33. Go to original source... Go to PubMed...
  11. Mitchell JH, Haskell W, Snell P, Camp SPV. Task Force 8: Classification of sports. J Am Coll Cardiol 2005;45:1364-1367. Go to original source... Go to PubMed...
  12. Aizawa Y, Negishi M, Kashimura S, et al. Predictive factors of lead failure in patients implanted with cardiac devices. Int J Cardiol 2015;199:277-281. Go to original source... Go to PubMed...
  13. Sacher F, Probst V, Maury P, et al. Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome. Circulation 2013;128:1739-1747. Go to original source... Go to PubMed...
  14. Saarel EV, Law I, Berul CI, et al. Safety of Sports for Young Patients With Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol 2018;11:e006305. Go to original source... Go to PubMed...
  15. Bennekers JH, van Mechelen R, Meijer A. Pacemaker safety and long-distance running. Neth Heart J 2004;12:450-454.
  16. Lampert R. Update on Sports Participation for Athletes with Implantable Cardioverter Defibrillators. Int J Cardiovasc Sci 2019;32:391-395. Go to original source...
  17. Moss AJ, Schuger C, Beck CA, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367:2275-2283. Go to original source... Go to PubMed...
  18. Heidbuchel H, Willems R, Jordaens L, et al. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort. Eur J Prev Cardiol 2019;26:764-775. Go to original source... Go to PubMed...
  19. Heidbuchel H, Olshansky B, Cannom D, et al. Intensive recreational vs. competitive athletes in the prospective multinational ICD Sports Safety Registry: results from the European recreational cohort. EP Eur 2017;19(Suppl. 3):iii121. Go to original source...
  20. Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66:2424-2428. Go to original source... Go to PubMed...
  21. Pelliccia A, Fagard R, Bjørnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease. A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:1422-1445. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.